77 related articles for article (PubMed ID: 3912040)
21. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].
Ariyoshi Y; Nukariya N; Akasaka Y; Suminaga M; Ota J; Ikeda M; Taguchi T
Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810
[TBL] [Abstract][Full Text] [Related]
22. Anti-emetic effect of high-dose metoclopramide vs alizapride--a randomised crossover study.
Seng KT; Tiong CE; Hiang TC
Br J Clin Pharmacol; 1994 Sep; 38(3):282-4. PubMed ID: 7826833
[TBL] [Abstract][Full Text] [Related]
23. Alizapride in the prevention of postoperative vomiting. A double-blind comparison.
Vanacker B; Van Aken H
Acta Anaesthesiol Belg; 1988; 39(4):247-50. PubMed ID: 3232497
[TBL] [Abstract][Full Text] [Related]
24. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
[TBL] [Abstract][Full Text] [Related]
25. [Comparative study of antiemetic properties of clebopride and metoclopramide in vomiting produced by cis-platinum (author's transl)].
Padrón F; Sanz J; Flórez J
Med Clin (Barc); 1981 Sep; 77(4):167-70. PubMed ID: 7031384
[No Abstract] [Full Text] [Related]
26. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
[TBL] [Abstract][Full Text] [Related]
27. [Randomized controlled study of high-dose metoclopramide (2 mg/kg x 4:H) vs moderate-dose metoclopramide (1 mg/kg x 4:M) in the prevention of CDDP-induced emesis].
Dozono H; Ohmi K
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):454-7. PubMed ID: 3954370
[TBL] [Abstract][Full Text] [Related]
28. Antiemetic efficacy of prochlorperazine, haloperidol, and droperidol in cisplatin-induced emesis.
Owens NJ; Schauer AR; Nightingale CH; Golub GR; Martin RS; Williams HM; Schauer PK
Clin Pharm; 1984; 3(2):167-70. PubMed ID: 6373102
[TBL] [Abstract][Full Text] [Related]
29. Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients.
Moreno I; Rosell R; Abad A; Barnadas A; Carles J; Ribelles N; Solano V; Font A
Eur J Cancer; 1992; 28A(8-9):1344-7. PubMed ID: 1515247
[TBL] [Abstract][Full Text] [Related]
30. The effect of administration rate on cisplatin-induced emesis.
Jordan NS; Schauer PK; Schauer A; Nightingale C; Golub G; Martin RS; Williams HM
J Clin Oncol; 1985 Apr; 3(4):559-61. PubMed ID: 3884747
[TBL] [Abstract][Full Text] [Related]
31. Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial.
Bleiberg H; Gerard B; Dalesio O; Crespeigne N; Rozencweig M
Cancer Chemother Pharmacol; 1988; 22(4):316-20. PubMed ID: 3048762
[TBL] [Abstract][Full Text] [Related]
32. Metoclopramide. A review of antiemetic trials.
Gralla RJ
Drugs; 1983 Feb; 25 Suppl 1():63-73. PubMed ID: 6682376
[TBL] [Abstract][Full Text] [Related]
33. [Benefit and risk of high-dose metoclopramide in comparison to high-dose haloperidol or triflupromazine in cisplatin-induced vomiting].
Saller R; Hellenbrecht D
Klin Wochenschr; 1985 May; 63(9):428-32. PubMed ID: 4039775
[TBL] [Abstract][Full Text] [Related]
34. Alizapride alone or alizapride-dexamethasone compared with metoclopramide-dexamethasone in patients at high risk of acute emesis after cisplatin. A randomized cross-over study.
Pollera CF; Nardi M; Marolla P; Calabresi F
Acta Oncol; 1991; 30(6):725-9. PubMed ID: 1958393
[TBL] [Abstract][Full Text] [Related]
35. Trial of droperidol as an antiemetic in cisplatin chemotherapy.
Kelley SL; Braun TJ; Meyer TJ; Rempel P; Pearlman NW
Cancer Treat Rep; 1986 Apr; 70(4):469-72. PubMed ID: 3698040
[TBL] [Abstract][Full Text] [Related]
36. [Randomized study of the antiemetic efficacy of alizapride versus alizapride + dexamethasone].
Epifani C; Scognamiglio G; Prete C; Alberio F; Gini G; Valli M
G Ital Oncol; 1990; 10(4):115-9. PubMed ID: 2093079
[TBL] [Abstract][Full Text] [Related]
37. High-dose alizapride versus high-dose domperidone: a double-blind comparative study in the management of cis-platinum-induced emesis.
Huys J; Troch M; Bourguignon RP; Smets P
Curr Med Res Opin; 1985; 9(6):400-6. PubMed ID: 3886305
[TBL] [Abstract][Full Text] [Related]
38. Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy.
Niederle N; Schütte J; Schmidt CG
Klin Wochenschr; 1986 Apr; 64(8):362-5. PubMed ID: 3009962
[TBL] [Abstract][Full Text] [Related]
39. Control of nephrotoxicity by hydration-diuresis, and of emesis by alizapride, during cisplatin administration in patients with bladder cancer.
Neri B; Bartalucci S; Rizzo P; Nicita G; Ponchietti R
Riv Eur Sci Med Farmacol; 1988 Nov; 10(5):389-92. PubMed ID: 3079128
[No Abstract] [Full Text] [Related]
40. High-dose metoclopramide and chlorpromazine in the treatment of cisplatin-induced emesis.
Aasebø U; Slørdal L; Prytz PS; Aarbakke J
Pharmacol Toxicol; 1987 May; 60(5):337-9. PubMed ID: 3303001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
